Your institution may have access to this item. Find your institution then sign in to continue.
Title
Cardizem LA.
Abstract
Provides information on Biovail Corp.'s extended-release calcium antagonist Cardizem LA, which has been approved by the U.S. Food and Drug Administration for the treatment of chronic stable angina.